Core Viewpoint - The Hong Kong stock market has experienced significant corrections, particularly in the internet and healthcare sectors, with the Hang Seng Technology Index down over 10% and the Hong Kong Stock Connect Healthcare Index down over 4.5% since February [1] Group 1: Market Performance - The recent pullback in the Hong Kong stock market is attributed more to short-term geopolitical factors affecting market sentiment rather than fundamental issues [1] - The high proportion of foreign capital in the Hong Kong investor structure makes it sensitive to geopolitical changes, leading to profit-taking and risk aversion among investors [1] Group 2: Healthcare Sector Insights - The healthcare sector in Hong Kong is characterized by high-quality, scarce assets, including leaders in internet healthcare, traditional Chinese medicine services, AI pharmaceuticals, and surgical robotics [2] - The CXO and internet healthcare segments are highlighted as core support areas due to their high growth rates and revenue certainty, with leading CXO companies showing superior income and profit growth compared to other pharmaceutical sub-sectors [2] - Internet healthcare is noted as one of the fastest-growing segments in pharmaceutical retail, leveraging AI and big data technologies to enhance patient access and prescription efficiency [2] Group 3: Internet Sector Valuation - The current price-to-earnings (PE) ratio of the Hong Kong Stock Connect Internet Index is only 22 times, placing it in the 20th percentile historically, indicating a significant valuation discount compared to global tech assets [2] - The internet giants are actively embracing AI technology, integrating model development and cloud computing as key growth areas, suggesting that the long-term growth logic remains intact [3]

Core Viewpoint - The article discusses the ETF grid strategy, focusing on specific ETFs that are expected to benefit from upcoming policy changes and market trends, particularly in the consumer and healthcare sectors in Hong Kong [2][3][5]. Group 1: Hong Kong Consumer 50 ETF - The Hong Kong Consumer 50 ETF (159268.SZ) is highlighted as a key focus, with historical data indicating that the period between the Spring Festival and the Two Sessions often leads to market speculation on policy expectations, particularly in the consumer sector [2]. - High-frequency data from the People's Bank of China shows that during the Spring Festival of 2026, transaction volumes reached 393.02 billion transactions, amounting to 13.12 trillion yuan, reflecting a 37.45% increase in transaction volume and a 19.26% increase in transaction value compared to the previous year [2]. - The ETF tracks the National Index of Hong Kong Consumer Theme, with a significant portion of its holdings in "new consumption" sectors such as trendy products and new-style tea drinks, which may exhibit higher elasticity under favorable policy expectations [3]. Group 2: Hong Kong Healthcare ETF - The Hong Kong Healthcare ETF (159366.SZ) has seen increased investment from southbound funds, with net purchases exceeding 150 billion HKD as of February 24, 2026, indicating strong liquidity in the healthcare sector [3]. - Data from the National Medical Products Administration shows that in 2025, the total value of authorized transactions for innovative drugs exceeded 130 billion USD, with over 150 transactions, marking a historical high [5]. - As of February 15, 2026, there have been 39 external authorization transactions for Chinese innovative drugs, with upfront payments totaling approximately 29.53 billion USD, showcasing the significant improvement in China's drug development capabilities [5]. Group 3: Securities and Insurance ETF - The Securities and Insurance ETF (512070.SH) reflects a robust bond issuance environment, with total bond issuance by brokerages reaching 426.04 billion yuan as of February 20, 2026, representing a year-on-year increase of 243.97% [7]. - The approval of bond issuance has reached 322 billion yuan in 2026, providing brokerages with low-cost long-term funding, which enhances their operational capabilities in various capital-intensive businesses [7]. - Recent regulatory measures aimed at optimizing refinancing processes are expected to benefit brokerage firms' investment banking operations, aligning with the policy direction of supporting strong firms while limiting weaker ones [8].

Group 1 - The core viewpoint of the report emphasizes the effectiveness of grid trading strategies, which capitalize on price fluctuations rather than predicting market trends, making them suitable for volatile markets [4][12] - The report identifies key characteristics for suitable grid trading targets, including being exchange-traded, having stable long-term trends, low transaction costs, good liquidity, and high volatility, with equity ETFs being particularly appropriate [4][12] Group 2 - The report highlights three specific ETFs for grid trading strategies: 1. The Hong Kong Stock Connect Consumer 50 ETF (159268.SZ), which shows signs of consumer recovery and potential policy stimulus ahead of the Two Sessions, with transaction data indicating a 37.45% increase in transaction volume during the 2026 Spring Festival compared to 2025 [4][13] 2. The Hong Kong Medical ETF (159366.SZ), benefiting from improved liquidity and a surge in global innovation drug transactions, with over 1,500 billion HKD net purchases from southbound funds in early 2026 [5][16] 3. The Securities and Insurance ETF (512070.SH), which has seen a significant increase in bond issuance by brokerages, with a total of 426.04 billion CNY raised, reflecting a 243.97% year-on-year growth, supported by favorable refinancing policies [6][7][18] Group 3 - The report suggests that investors can enhance their grid trading strategies by diversifying their ETF selections, combining different types or investment ranges to mitigate risks and improve capital efficiency [21]

Market Performance - The A-share market returned to 3900 points, with the Shanghai Composite Index rising by 0.69%, the Shenzhen Component Index increasing by 1.47%, and the ChiNext Index up by 2.23% [1] - The total market turnover reached 186.5 billion yuan, an increase of 11.63 billion yuan compared to the previous day [1] Sector Performance - Active sectors included Hainan, storage chips, and precious metals, while the pharmaceutical commercial and film industry sectors experienced adjustments [1] - In the ETF market, the US biotechnology sector saw gains, with the Harvest Fund S&P Biotechnology ETF and the Huatai-PineBridge Fund NASDAQ Biotechnology ETF rising by 5.01% and 4.88%, respectively [1] - The semiconductor sector experienced a broad increase, with the Guotai Fund Semiconductor Equipment ETF, GF Fund Chip Equipment ETF, and Wanji Fund Semiconductor Equipment ETF rising by 4.93%, 4.92%, and 4.82%, respectively [1] - The CPO sector rebounded strongly, with the Guotai Fund Communication ETF and Bosera Fund 5G50 ETF both increasing by 4% [1] - Gold reached a new historical high, with the Huaxia Fund Gold Stock ETF and Ping An Fund Gold Stock ETF rising by 3.7% [1] Hong Kong Market - The Hong Kong medical sector declined, with the Hong Kong Innovative Drug 50 ETF, Hang Seng Biotechnology ETF, Hong Kong Medical ETF, and Hong Kong Stock Connect Medical ETF all falling by 1% [1] - The film sector also weakened, with the film ETF dropping by 1.29% [1]

Group 1 - The A-share market has returned to 3900 points, with the Shanghai Composite Index rising by 0.64%, the Shenzhen Component Index increasing by 1.36%, and the ChiNext Index up by 1.8% [1] - The total market turnover reached 1,198.9 billion yuan, an increase of 95.4 billion yuan compared to the previous day [1] - Stocks related to the Hainan Free Trade Zone experienced a surge, while the semiconductor industry chain saw significant gains, and sectors such as computing hardware, stablecoins, robotics, intelligent driving, and duty-free shops were actively performing [1] Group 2 - In the ETF market, the semiconductor sector saw a broad increase, with funds like GF Fund's Chip Equipment ETF, Guotai Fund's Semiconductor Equipment ETF, and Wanji Fund's Semiconductor Equipment ETF rising over 4% [1] - The CPO sector rebounded strongly, with Guotai Fund's Communication ETF increasing by 4.18% [1] - Gold reached a new historical high, with Huaxia Fund's Gold Stock ETF rising by 3.73% [1] Group 3 - The Hong Kong stock market's healthcare sector declined, with both the Hong Kong Healthcare ETF and the Hong Kong Stock Connect Healthcare ETF falling by 1% [1] - The film and television sector weakened, with the Film and Television ETF dropping by 0.86% [1]

Market Performance - On December 19, all three major A-share indices closed higher, with over 80% of more than 1,300 ETFs in the market also rising [1] - The Hong Kong automotive-themed ETFs led the market, with six products ranking among the top ten in daily gains, each rising over 3% [1] Trading Activity - ETF trading was active, with total trading volume exceeding 450 billion yuan, an increase of nearly 25 billion yuan from the previous day [2] - Twelve ETFs had trading volumes exceeding 10 billion yuan, with several bond ETFs seeing significant increases in trading volume [2][6] Net Inflows - On December 18, the ETF market saw a net inflow of over 17 billion yuan, marking the third consecutive day of net inflows exceeding 10 billion yuan [3][8] - Over the past five trading days, the total net inflow into ETFs has surpassed 87 billion yuan [3] Sector Performance - The Hong Kong automotive ETFs performed exceptionally well, with six out of seven ETFs in this category seeing gains, and 38 out of 46 component stocks closing higher [4] - The total scale of the seven Hong Kong automotive ETFs is approximately 1.168 billion yuan, with the largest ETF having a scale of about 528 million yuan [4] Specific ETF Performance - The top-performing ETFs on December 19 included several automotive and tourism ETFs, with notable gains ranging from 2.92% to 3.35% [5] - Bond ETFs were particularly active, with the Shanghai Company Bond ETF's trading volume increasing to over 10 billion yuan, a 4.2-fold increase from the previous day [6][7] Investment Trends - The A500 ETF and the Sci-Tech Bond ETF attracted significant net inflows, with the A500 ETF seeing over 4 billion yuan in net inflows on December 18 [8][9] - Conversely, several military-themed ETFs experienced substantial net outflows, totaling over 2.9 billion yuan in the past five trading days [10] Fund Management Changes - Multiple ETFs announced changes to their fund names, aligning with new regulations from the Shanghai and Shenzhen stock exchanges [11] Sector Insights - Investment opportunities in the innovative pharmaceutical sector are gaining attention, with expectations for a stable upward trend in 2026 [12] - Analysts suggest focusing on companies with global intellectual property and strong cash flow in the pharmaceutical sector [12]

Group 1 - The ETF market showed mixed performance at the midday close on December 19, with notable gains in healthcare ETFs and losses in oil and gas ETFs [1][2] - The Hong Kong Medical ETF (159366) increased by 3.56%, while the Hong Kong Medical Connect ETF (520510) rose by 3.14% [1][2] - The Hong Kong Innovative Drug 50 ETF (513780) saw a gain of 3.00%, contrasting with declines in the S&P Oil & Gas ETF (513350) which fell by 1.07% and the Shenzhen 100 ETF Huazhong (159706) which decreased by 0.67% [1][2]

Core Viewpoint - The Hong Kong stock market is currently experiencing a significant left-side layout opportunity due to the release of multiple negative factors that previously suppressed the market, with valuations remaining low or reasonable, and marginal positive factors accumulating for medium to long-term recovery [1][3]. Valuation and Market Position - The Hong Kong stock market is viewed as a "global valuation pit," with major indices showing improved safety margins after adjustments. The Hang Seng Index, despite a significant rebound from its 2024 low, still presents attractive valuations compared to other major markets [1]. - The technology sector's valuation is at historical lows, with the Hong Kong Internet PE-TTM at 25.44 times, which is 58.45% of its historical average, indicating it is cheaper than nearly 40% of the past decade [1][3]. Drivers for Left-Side Layout - Negative factors that previously pressured the market, such as uncertainties in US-China relations and concerns over the internet industry's profitability, have been largely released. The market is nearing a "bad news fully priced in" state, suggesting limited downside [3]. - Positive factors are accumulating, including potential boosts from future industrial policies and breakthroughs in AI technology, which could provide new growth logic for leading companies. Historical data shows that Hong Kong tech assets perform well after interest rate cuts by the Federal Reserve [3]. Capital Flow and Buybacks - There are signs of improvement in capital flow, with significant inflows from southbound capital, totaling 1.39 trillion this year, and a total market value of 6.27 trillion. Notable buybacks from companies like Tencent and Xiaomi indicate recognition of their own value [3][4]. - In the past month, Tencent and Xiaomi executed substantial buybacks of 7 billion and 2 billion HKD, respectively, reflecting confidence in their stock valuations [4][5]. Future Market Outlook - The market is expected to transition from valuation recovery to profit growth by 2026, with a focus on sectors like the internet and pharmaceuticals, where earnings expectations remain stable [6]. - Leading internet companies are shifting from cash-burning models to AI-driven commercial growth, with significant progress noted in companies like Tencent and Alibaba [6]. - High-quality value stocks in finance and consumer sectors, characterized by low valuations and improving cycles, align with the "left-side layout true value" strategy [6]. Investment Products and Strategies - The Hong Kong stock index product line is comprehensive, covering various attractive investment directions, including large-cap indices and thematic ETFs focused on technology and healthcare [8][9]. - Investors are encouraged to consider a gradual accumulation strategy during market fluctuations, as the current environment offers a high cost-performance ratio for long-term value-focused investors [11].

Market Performance - The Shanghai Composite Index rose by 0.49% at midday, while the ChiNext Index increased by 0.56%, having once surged over 2% [1] - The consumer electronics and HBM concepts led the gains, while the OCS concept remained strong, and solid-state battery concepts performed well [1] - Real estate stocks showed signs of recovery after hitting a low [1] ETF Movements - Some cross-border ETFs strengthened, with E Fund's Brazil ETF and Harvest Fund's S&P Biotechnology ETF rising by 2.56% and 2.28% respectively [1] - The semiconductor sector led the gains, with Guotai Fund's Integrated Circuit ETF, Harvest Fund's Integrated Circuit ETF, and Huatai-PB Fund's China-Korea Semiconductor ETF increasing by 2.32%, 1.92%, and 1.83% respectively [1] - The AI hardware sector continued its upward trend, with Guotai Fund's Communication ETF rising by 1.88% [1] - The consumer electronics sector was active, with Guotai Fund's Consumer Electronics ETF increasing by 1.63% [1] Hong Kong Market Trends - The healthcare sector in Hong Kong declined, with the Hong Kong Healthcare ETF and Hong Kong Stock Connect Healthcare ETF falling by 1.66% and 1.31% respectively [1] - The film and television sector also saw a downturn, with the Film and Television ETF dropping by 1.3% [1] - The technology sector in Hong Kong experienced a decline, with the Hong Kong Stock Connect Internet ETF decreasing by 1% [1]

Group 1 - The CRO concept stocks are experiencing a collective rebound, with the CSI Hong Kong Stock Connect Medical Theme Index rising by 2.73% as of November 24, 2025 [1] - Notable individual stock performances include Tigermed (03347) increasing over 9%, and other companies like Hansoh Pharmaceutical (03692), MicroPort Medical (00853), and WuXi AppTec (02359) also seeing gains [1][2] - The Hong Kong Medical ETF (159366) has risen over 2%, and over the past six months, it has accumulated a 29.35% increase [1][2] Group 2 - The innovative drug industry is benefiting from dual advantages of policy support and explosive demand, which are activating new drug research and development needs, positively impacting the CXO sector [3] - Among 29 listed companies in the A-share CXO sector, 20 reported year-on-year revenue growth in the first three quarters, indicating strong industry resilience [3] - WuXi AppTec's unique "integrated, end-to-end" CRDMO business model has driven steady growth, with total revenue of 32.86 billion yuan in the first three quarters of 2025, a year-on-year increase of 18.6%, and net profit attributable to shareholders rising by 84.8% to 12.08 billion yuan [3] Group 3 - The high growth of the CXO sector is supported by the trend of pharmaceutical companies outsourcing R&D and production to specialized CXO firms, which helps reduce costs and improve efficiency [4] - CXO companies are enhancing their service capabilities through continuous technological development and scale expansion, leading to deeper integration with pharmaceutical companies [4] - As of October 31, 2025, the top ten weighted stocks in the CSI Hong Kong Stock Connect Medical Theme Index accounted for 62.83% of the index, indicating a high concentration in the market [4]